Shaimaa Abdel-Ghany

834 total citations · 1 hit paper
42 papers, 500 citations indexed

About

Shaimaa Abdel-Ghany is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shaimaa Abdel-Ghany has authored 42 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Shaimaa Abdel-Ghany's work include MicroRNA in disease regulation (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Circular RNAs in diseases (5 papers). Shaimaa Abdel-Ghany is often cited by papers focused on MicroRNA in disease regulation (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Circular RNAs in diseases (5 papers). Shaimaa Abdel-Ghany collaborates with scholars based in Egypt, Saudi Arabia and Germany. Shaimaa Abdel-Ghany's co-authors include Hussein Sabit, Mohamed Abdel-Hakeem, Hüseyin Tombuloğlu, Emre Çevik, Tahsin Shoala, Borros Arneth, Amany I. Alqosaibi, Güzin Tombuloğlu, Manel Esteller and Suriya Rehman and has published in prestigious journals such as Scientific Reports, Molecules and Molecular Cancer.

In The Last Decade

Shaimaa Abdel-Ghany

41 papers receiving 495 citations

Hit Papers

Preci... 2025 2026 2025 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaimaa Abdel-Ghany Egypt 14 244 85 82 67 67 42 500
Wenxuan Guo China 13 278 1.1× 119 1.4× 111 1.4× 84 1.3× 36 0.5× 19 557
Deepa Dehari India 12 267 1.1× 105 1.2× 99 1.2× 47 0.7× 91 1.4× 23 555
Erica Miraglia Italy 10 233 1.0× 77 0.9× 72 0.9× 112 1.7× 85 1.3× 11 643
Jingbin� Huang China 14 361 1.5× 106 1.2× 70 0.9× 70 1.0× 101 1.5× 34 627
Biswa Prasun Chatterji India 9 316 1.3× 68 0.8× 76 0.9× 86 1.3× 44 0.7× 18 536
Bessi Qorri Canada 12 188 0.8× 108 1.3× 123 1.5× 99 1.5× 47 0.7× 24 557
Changmai Chen China 14 407 1.7× 67 0.8× 41 0.5× 40 0.6× 55 0.8× 23 634
Aiswarya Chaudhuri India 15 313 1.3× 140 1.6× 167 2.0× 72 1.1× 119 1.8× 28 626
Pegah Varamini Australia 15 440 1.8× 87 1.0× 101 1.2× 101 1.5× 30 0.4× 42 772
Diana Aparecida Dias Câmara Brazil 9 211 0.9× 82 1.0× 39 0.5× 49 0.7× 62 0.9× 17 472

Countries citing papers authored by Shaimaa Abdel-Ghany

Since Specialization
Citations

This map shows the geographic impact of Shaimaa Abdel-Ghany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaimaa Abdel-Ghany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaimaa Abdel-Ghany more than expected).

Fields of papers citing papers by Shaimaa Abdel-Ghany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaimaa Abdel-Ghany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaimaa Abdel-Ghany. The network helps show where Shaimaa Abdel-Ghany may publish in the future.

Co-authorship network of co-authors of Shaimaa Abdel-Ghany

This figure shows the co-authorship network connecting the top 25 collaborators of Shaimaa Abdel-Ghany. A scholar is included among the top collaborators of Shaimaa Abdel-Ghany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaimaa Abdel-Ghany. Shaimaa Abdel-Ghany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel-Ghany, Shaimaa, et al.. (2025). Therapeutic potential of brentuximab vedotin in breast cancer and lymphoma via targeted apoptosis and gene regulation. Scientific Reports. 15(1). 1824–1824.
2.
Abdel-Ghany, Shaimaa, et al.. (2025). Expression profiles of miR-101-3p and miR-431-5p as potential diagnostic biomarkers for rheumatoid arthritis. Scientific Reports. 15(1). 776–776. 1 indexed citations
3.
Sabit, Hussein, Borros Arneth, Timothy M. Pawlik, et al.. (2025). Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance. Pharmaceuticals. 18(1). 75–75. 16 indexed citations
4.
Abdel-Ghany, Shaimaa, et al.. (2025). Dysregulation of MiRNAs in schizophrenia in an Egyptian patient population. Scientific Reports. 15(1). 16998–16998. 2 indexed citations
5.
Ismail, Hisham, et al.. (2025). Anti-Tumor Potential of Frankincense Essential Oil and Its Nano-Formulation in Breast Cancer: An In Vivo and In Vitro Study. Pharmaceutics. 17(4). 426–426. 1 indexed citations
6.
Sabit, Hussein, et al.. (2025). Antibody–Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies. Biomedicines. 13(9). 2227–2227. 1 indexed citations
7.
Sabit, Hussein, et al.. (2024). Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants. Inflammopharmacology. 32(6). 3631–3652. 4 indexed citations
8.
Sabit, Hussein, Borros Arneth, Shaimaa Abdel-Ghany, et al.. (2024). Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression. Cells. 13(19). 1666–1666. 16 indexed citations
9.
Sabit, Hussein, Timothy M. Pawlik, Shaimaa Abdel-Ghany, & Borros Arneth. (2024). Defensins: Exploring Their Opposing Roles in Colorectal Cancer Progression. Cancers. 16(15). 2622–2622. 2 indexed citations
10.
Abdel-Ghany, Shaimaa, Amany I. Alqosaibi, Afnan Almuhanna, et al.. (2024). Metabolites in the Dance: Deciphering Gut-Microbiota-Mediated Metabolic Reprogramming of the Breast Tumor Microenvironment. Cancers. 16(24). 4132–4132. 3 indexed citations
11.
Abdel-Ghany, Shaimaa, et al.. (2024). Trastuzumab Induces Apoptosis and Cell Cycle Arrest in Triple-Negative Breast Cancer, Suggesting Repurposing Potential. Breast Cancer Basic and Clinical Research. 18. 782023971–782023971. 1 indexed citations
12.
Sabit, Hussein, et al.. (2023). The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients. Current Issues in Molecular Biology. 45(5). 4080–4099. 25 indexed citations
13.
Sabit, Hussein, et al.. (2021). Molecular characterization and phylogenetic analysis of Rhynchophorus ferrugineus (Olivier) in Eastern Province, Saudi Arabia. Saudi Journal of Biological Sciences. 28(10). 5621–5630. 10 indexed citations
14.
Sabit, Hussein, Shaimaa Abdel-Ghany, Hüseyin Tombuloğlu, et al.. (2021). New insights on CRISPR/Cas9-based therapy for breast Cancer. Genes and Environment. 43(1). 15–15. 17 indexed citations
15.
Sabit, Hussein, Hüseyin Tombuloğlu, Suriya Rehman, et al.. (2021). Gut microbiota metabolites in autistic children: An epigenetic perspective. Heliyon. 7(1). e06105–e06105. 22 indexed citations
16.
Abdel-Ghany, Shaimaa, Hüseyin Tombuloğlu, Mehmet Şenel, et al.. (2020). Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation. 3 Biotech. 10(9). 407–407. 24 indexed citations
17.
Sabit, Hussein, Emre Çevik, Hüseyin Tombuloğlu, et al.. (2020). Triple negative breast cancer in the era of miRNA. Critical Reviews in Oncology/Hematology. 157. 103196–103196. 48 indexed citations
18.
Khan, Suliman, Hüseyin Tombuloğlu, Suriya Rehman, et al.. (2020). Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective. European Journal of Pharmacology. 886. 173447–173447. 23 indexed citations
19.
Sabit, Hussein, Emre Çevik, Hüseyin Tombuloğlu, et al.. (2019). miRNA Profiling in MCF-7 Breast Cancer Cells: Seeking a New Biomarker. Journal of Biomedical Science. 8(2). 5 indexed citations
20.
Abdel-Ghany, Shaimaa, et al.. (2019). Titanium Oxide Nanoparticles Improve the Chemotherapeutic Action of Erlotinib in Liver Cancer Cells. Current Cancer Therapy Reviews. 16(4). 337–343. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026